POLYMED — Poly Medicure Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for Poly Medicure, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,231	11,152	13,758	16,698	18,753
Cost of Revenue
Gross Profit	4,898	6,059	7,715	9,634	12,784
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,639	9,067	10,786	12,973	15,553
Operating Profit	1,591	2,085	2,972	3,725	3,200
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,952	2,375	3,443	4,525	4,275
Provision for Income Taxes
Net Income After Taxes	1,465	1,793	2,583	3,386	3,207
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,465	1,793	2,583	3,386	3,221
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,465	1,793	2,583	3,386	3,221
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.2	18.7	26.6	33.9	32.3
Dividends per Share